A clinical evaluation of 873 patients reported that real-time PCR with melting curve analysis accurately detects drug-resistant pulmonary tuberculosis, while sensitivity drops for resistance detection in extrapulmonary specimens. The findings highlight specimen-type dependence in molecular resistance workflows. For diagnostic developers and health systems, the data supports tighter use-case targeting and may inform how labs triage samples, interpret negative results and decide confirmatory steps. —